Cargando…

The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy

Objective: The aim of this study is to investigate the role of prophylactic anticoagulation regimens based on low molecular weight heparin (LMWH) or aspirin in thromboembolic events in patients with primary membranous nephropathy (PMN). Methods: A total of 717 patients with PMN were consecutively en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Peimei, Li, Hang, Cai, Jianfang, Li, Chao, Chen, Zhenjie, Li, Xuewang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609351/ https://www.ncbi.nlm.nih.gov/pubmed/31269849 http://dx.doi.org/10.1080/0886022X.2019.1635030

Ejemplares similares

Statins can benefit patients with primary membranous nephropathy on venous thromboembolism
por: Zou, Peimei, et al.
Publicado: (2021)

The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials
por: Meng, Jiahao, et al.
Publicado: (2023)

Prophylactic Aspirin and Public
por: Morgan, Gareth
Publicado: (2013)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial
por: Haac, Bryce E., et al.
Publicado: (2020)

Risk‐Stratified Venous Thromboembolism Prophylaxis after Total Joint Arthroplasty: Low Molecular Weight Heparins and Sequential Aspirin vs Aggressive Chemoprophylaxis
por: Peng, Hui‐ming, et al.
Publicado: (2021)

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

Aspirin/low-molecular-weight-heparins/methylprednisolone: Lack of efficacy: case report
Publicado: (2022)

The Safety and Efficacy of Rituximab-Based Regimen in Atypical Membranous Nephropathy: A Single Center Retrospective Cohort Study
por: Liu, Yanan, et al.
Publicado: (2023)

Inpatient compliance with venous thromboembolism prophylaxis after orthopaedic trauma: results from a randomized controlled trial of aspirin versus low molecular weight heparin
por: Haac, Bryce E., et al.
Publicado: (2021)

A direct comparison of prophylactic low-molecular-weight heparin versus unfractionated heparin in neurosurgery: A meta-analysis
por: Macki, Mohamed, et al.
Publicado: (2019)

Venous thrombotic events in severe and critically COVID-19 patients despite high dose prophylactic low-molecular-weight heparin
por: Visser, Chantal, et al.
Publicado: (2020)

Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study
por: Kumar, Sanjeev, et al.
Publicado: (2012)

Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Aspirin/heparin: Intracerebral haemorrhage: case report
Publicado: (2021)

Aspirin/heparin: Lack of efficacy: case report
Publicado: (2022)

A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy
por: Sasaki, Kosaku, et al.
Publicado: (2022)

Unfractionated heparin or low-molecular-weight heparin for venous thromboembolism prophylaxis after hepatic resection: A meta-analysis
por: Zhang, Wentao, et al.
Publicado: (2022)

Subcutaneous hematomas from prophylactic heparin use
por: Koratala, Abhilash, et al.
Publicado: (2017)

Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients
por: Stattin, K., et al.
Publicado: (2020)

Prophylactic anticoagulation with low molecular weight heparin in COVID-19: cohort studies in Denmark and Sweden
por: Lund, Lars Christian, et al.
Publicado: (2022)

Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer
por: Lee, Jang Ho, et al.
Publicado: (2019)

Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism
por: Coleman, Craig I., et al.
Publicado: (2023)

Thromboembolic events and apparent heparin resistance in patients infected with SARS‐CoV‐2
por: Beun, Robert, et al.
Publicado: (2020)

Aspirin and Low-Molecular Weight Heparin Combination Therapy Effectively Prevents Recurrent Miscarriage in Hyperhomocysteinemic Women
por: Chakraborty, Pratip, et al.
Publicado: (2013)

Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage
por: Elmahashi, Mohamed O, et al.
Publicado: (2014)

Grape seed proanthocyanidins protect against streptozotocin-induced diabetic nephropathy by attenuating endoplasmic reticulum stress-induced apoptosis
por: Gao, Zhaoli, et al.
Publicado: (2018)

Extensive Thrombosis in a Severe COVID-19 Patient Despite Prophylactic Low Molecular Weight Heparin
por: Elkattawy, Sherif, et al.
Publicado: (2020)

An impaired hepatic clock system effects lipid metabolism in rats with nephropathy
por: Chen, Peipei, et al.
Publicado: (2018)

Potential Application of Copper Aspirinate in Preventing and Treating Thromboembolic Diseases
por: Liu, Weiping, et al.
Publicado: (1998)

Efficacy and safety of low-dose aspirin combined with low-molecular-weight heparin in treatment of preeclampsia: a meta-analysis and systematic review
por: Wu, Chunfeng, et al.
Publicado: (2021)

Low-Molecular-Weight Heparin Use in a Case of Noncardiogenic Multifocal Perinatal Thromboembolic Stroke
por: Saxonhouse, Matthew A., et al.
Publicado: (2009)

Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins
por: Smrke, Alannah, et al.
Publicado: (2017)

Effect of hydrocolloid dressing combined with low molecular weight heparin and calcium on scar hyperplasia in burn patients with venous thromboembolism
por: Li, Chengzhi, et al.
Publicado: (2023)

Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome
por: XIAO, JING, et al.
Publicado: (2013)

Comparison of the Efficacy and Safety of Aspirin and Low-Molecular-Weight Heparin in Patients With a Fracture: A Meta-Analysis
por: Nimerta, FNU, et al.
Publicado: (2023)

Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis
por: Zheng, Li, et al.
Publicado: (2022)

Aspirin/enoxaparin sodium/heparin: Bleeding: 3 case reports
Publicado: (2021)

Aspirin/enoxaparin-sodium/heparin: Lack of efficacy: case report
Publicado: (2021)

Prevalence of thromboembolic events and status of prophylactic anticoagulant therapy in hospitalized patients with COVID-19 in Japan
por: Fujiwara, Sho, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j7j6tluvc7b8v7e50urj3b7rc6